The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
Many people use over-the-counter remedies to ease flu symptoms, but people with a common health condition should take care ...
Interesting Engineering on MSN1h
US approves first nasal spray for major depressive disorder, PTSD conditionsJohnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...
A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...
The expert continued: " If your blood pressure is within a healthy range and you have no heart-related concerns, short-term use of decongestants as directed is generally safe. However, for individuals ...
Munson Healthcare is taking steps to make sure Narcan is accessible to everyone.It's partnering with Harm Reduction Michigan ...
Eurofins CDMO Amatsiaquitaine S.A.S., the GMP manufacturer, to support Polyrizon in future commercialization efforts Raanana, Israel, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (the "Company" or ...
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback